We aimed to evaluate the role of kidney injury molecule-1 (KIM-1) in determining the intervals between shockwave lithotripsy (SWL) sessions.
Patients and Methods:
This was a prospective, controlled study. It included 40 patients with unilateral kidney stones and 40 healthy persons of a similar age group as controls. The patients' midflow urine samples were collected before SWL and 1 hour, 1 day, 1 week, and 1 month after the procedure.
Results:
The average age in the SWL and control groups was 45 ± 14 and 39 ± 15 years, respectively (P = 0.336). The average KIM-1 value before SWL was 0.74 ± 0.35 ng/mL, which was significantly higher than that of the control group (0.51 ± 0.14 ng/mL) (P < 0.001). Similarly, the average values of the urine samples after SWL were higher than those of the control group (P < 0.001). When the KIM-1 values of the patients given SWL were compared within the group, the KIM-1 values 1 hour (1.06 ± 0.51) and 1 day (0.99 ± 0.67) after the procedure were statistically clearly higher than those before the procedure (P < 0.001) and statistically clearly higher than those of the control group (P = 0.005). The KIM-1 values 1 week and 1 month after the procedure were not significantly different than the preprocedure values (P = 0.652 and P = 0.747, respectively).
Conclusion:
KIM-1 is a noninvasive biomarker that may be used to show renal damage because of stones and early-stage renal damage linked to SWL. In addition, post-SWL KIM-1 values may be used to determine the interval between SWL sessions.
Get full access to this article
View all access options for this article.
References
1.
WenCC, NakadaSY. Treatment selection and outcomes: Renal calculi. Urol Clin North Am, 2007; 34:409–419.
2.
PremingerGM. Management of lower pole renal calculi: Shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy. Urol Res, 2006; 34:108–111.
3.
LiX, LongQ, ChengX, HeD. Shock wave induces biological renal damage by activating excessive inflammatory responses in rat model. Inflammation, 2014; 37:1317–1325.
4.
IchimuraT, BonventreJV, BaillyV, et al.Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem, 1998; 273:4135–4142.
5.
ZhangPL, MashniJW, SabbisettiVS, et al.Urine kidney injury molecule-1: A potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol, 2014; 46:379–388.
6.
SeoMS, ParkMY, ChoiSJ, et al.Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. BMC Nephrol, 2013; 14:139.
7.
VaidyaVS, RamirezV, IchimuraT, et al.Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol, 2006; 290:F517–F529.
8.
KarlsenSJ, BergKJ. Acute changes in kidney function following extracorporeal shock wave lithotripsy for renal stones. Br J Urol, 1991; 67:241–245.
9.
CeylanC, DoganS, SaydamG, et al.Evaluation of the process of recycling and renal parenchymal injury after eswl with metabolites excreted in the urine. Ren Fail, 2013; 35:466–471.
10.
DevarajanP. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr, 2011; 23:194–200.
11.
NajemGR, SeebodeJJ, SamadyAJ, et al.Stressful life events and risk of symptomatic kidney stones. Int J Epidemiol, 1997; 26:1017–1023.
12.
AksoyY, MalkocI, AtmacaAF, et al.The effects of extracorporeal shock wave lithotripsy on antioxidant enzymes in erythrocytes. Cell Biochem Funct, 2006; 24:467–469.
13.
HatipoğluNK, EvliyaoğluO, IşikB, et al.Antioxidant signal and kidney injury molecule-1 levels in shockwave lithotripsy induced kidney injury. J Endourol, 2014; 28:224–228.
14.
YilmazE, HaciislamogluA, KisaU, et al.Ways in which SWL affects oxidant/antioxidant balance. Urolithiasis, 2013; 41:137–141.
15.
MostafaviMR, ChavezDR, CannilloJ, et al.Redistribution of renal blood flow after SWL evaluated by Gd-DTPA-enhanced magnetic resonance imaging. J Endourol, 1998; 12:9–12.
16.
JohanssonM, SörensenV, JonssonO, et al.Examination of intrarenal blood flow by Doppler ultrasound before and after extracorporeal shock wave lithotripsy for urolithiasis. Scand J Urol Nephrol, 1997; 31:27–30.
17.
GolovanovSA, IanenkoEK, DzeranovNK, et al.[Lipid peroxidation and the antioxidant system of patients with urolithiasis after extracorporeal lithotripsy.]. (Rus) Urol Nefrol (Mosk), 1998; 2:14–16.
18.
IchimuraT, HungCC, YangSA, et al.Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol, 2004; 286:F552–F563.
19.
Van TimmerenMM, Van den HeuvelMC, BaillyV, et al.Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol, 2007; 212:209–217.
20.
ZhangPL, RothblumLI, HanWK, et al.Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury. Kidney Int, 2008; 73:608–614.
21.
IchimuraT, AsseldonkEJ, HumphreysBD, et al.Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest, 2008; 118:1657–1668.
22.
LimAI, TangSC, LaiKN, LeungJC. Kidney injury molecule-1: More than just an injury marker of tubular epithelial cells?. J Cell Physiol, 2013; 228:917–924.
23.
PeraltaCA, KatzR, BonventreJV, et al.Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis, 2012; 60:904–911.
24.
AbassiZ, ShalabiA, SohotnikR, et al.Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. J Urol, 2013; 189:1559–1566.
25.
ZhouY, VaidyaVS, BrownRP, et al.Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci, 2008; 101:159–170.
26.
ChiusoloA, DefazioR, ZanettiE, et al.Kidney injury molecule-1 expression in rat proximal tubule after treatment with segment-specific nephrotoxicants: A tool for early screening of potential kidney toxicity. Toxicol Pathol, 2010; 38:338–345.
27.
LegrandM, GayatE. Novelties in biomarkers for the management of circulatory failure. Curr Opin Crit Care, 2013; 19:410–416.
28.
PetersHP, WaandersF, MeijerE, et al.High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant, 2011; 26:3581–3588.
29.
KhanSR. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: Evidence from clinical and experimental investigations. J Urol, 2013; 189:803–811.
30.
TanriverdiO, TelciD, AydinM, et al.Hyperoxaluria-induced tubular ischemia: The effects of verapamil and vitamin E on apoptotic changes with an emphasis on renal papilla in rat model. Urol Res, 2012; 40:17–25.
31.
TurkC, KnollT, PetrikA, et al.Guidelines on urolithiasis. 2014, pp 1–98. Available at: uroweb.org. Accessed: September7, 2015.
32.
VillanyiKK, SzekelyJG, FarkasLM, et al.Short-term changes in renal function after extracorporeal shock wave lithotripsy in children. J Urol, 2001; 166:222–224.
TokerA, ZiypakT, OrsalE, et al.Is urinary kidney injury molecule-1 a noninvasive marker for renal scarring in children with vesicoureteral reflux?. Urology, 2013; 81:168–172.
35.
KrambeckAE, GettmanMT, RohlingerAL, et al.Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol, 2006; 175:1742–1747.
